Compile Data Set for Download or QSAR
Report error Found 88 Enz. Inhib. hit(s) with all data for entry = 50009460
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083811(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50: 2.30nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083839(2-Benzyloxycarbonylamino-3-({1-[3-(4,5-dihydro-1H-...)
Affinity DataIC50: 3.80nMAssay Description:Inhibition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083823(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50: 4.70nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083797(2-(3,5-Dimethyl-biphenyl-4-sulfonylamino)-3-({1-[3...)
Affinity DataIC50: 4.90nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083803(2-Benzyloxycarbonylamino-3-({1-[3-(4,5-dihydro-1H-...)
Affinity DataIC50: 7.30nMAssay Description:Inhibition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083836(2-(2,6-Dichloro-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50: 8.5nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083837(2-(4-Chloro-benzenesulfonylamino)-3-({1-[3-(1H-imi...)
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083810(2-(2,6-Dimethyl-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083807(2-(3,4-Dichloro-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50: 10nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083836(2-(2,6-Dichloro-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50: 12nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083812(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50: 13nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083833(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50: 16nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083811(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50: 21nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083793(2-Benzyloxycarbonylamino-3-({2-[3-(4,5-dihydro-1H-...)
Affinity DataIC50: 25nMAssay Description:Inhibition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083802(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50: 25nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alphaV-beta3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083809(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50: 26nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083814(3-({1-[3-(1,4,5,6-Tetrahydro-pyrimidin-2-ylamino)-...)
Affinity DataIC50: 28nMAssay Description:Inhibition of adhesion of integrin beta-3-transfected HEK293 cells to fibrinogenMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083785(3-({5-[3-(1H-Imidazol-2-ylcarbamoyl)-propyl]-4,5-d...)
Affinity DataIC50: 31nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083799(2-Benzenesulfonylamino-3-({1-[3-(1H-imidazol-2-yla...)
Affinity DataIC50: 34nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083805(2-(Biphenyl-4-sulfonylamino)-3-({1-[3-(1H-imidazol...)
Affinity DataIC50: 35nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083812(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50: 39nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083799(2-Benzenesulfonylamino-3-({1-[3-(1H-imidazol-2-yla...)
Affinity DataIC50: 44nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083813(3-({1-[3-(Pyridin-2-ylamino)-propyl]-1H-indazole-5...)
Affinity DataIC50: 48nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083801(2-Benzyloxycarbonylamino-3-({1-[2-(4,5-dihydro-1H-...)
Affinity DataIC50: 51nMAssay Description:Inhibition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083816(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50: 52nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083828(2-Benzyloxycarbonylamino-3-({2-[3-(4,5-dihydro-1H-...)
Affinity DataIC50: 55nMAssay Description:Inhibition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083794(3-({1-[2-(1H-Imidazol-2-ylcarbamoyl)-ethyl]-1H-ind...)
Affinity DataIC50: 56nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083821(3-({1-[3-(4,5-Dihydro-1H-imidazol-2-ylamino)-propy...)
Affinity DataIC50: 57nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083814(3-({1-[3-(1,4,5,6-Tetrahydro-pyrimidin-2-ylamino)-...)
Affinity DataIC50: 66nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083821(3-({1-[3-(4,5-Dihydro-1H-imidazol-2-ylamino)-propy...)
Affinity DataIC50: 70nMAssay Description:Inhibition of adhesion of integrin beta-3-transfected HEK293 cells to fibrinogenMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083797(2-(3,5-Dimethyl-biphenyl-4-sulfonylamino)-3-({1-[3...)
Affinity DataIC50: 74nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083832(2-Benzyloxycarbonylamino-3-({1-[3-(1H-imidazol-2-y...)
Affinity DataIC50: 74nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083810(2-(2,6-Dimethyl-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50: 74nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083823(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50: 81nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083833(3-({1-[3-(1H-Imidazol-2-ylamino)-propyl]-1H-indazo...)
Affinity DataIC50: 83nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083831(2-(4-tert-Butyl-benzenesulfonylamino)-3-({1-[3-(1H...)
Affinity DataIC50: 120nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083798(2-Benzenesulfonylamino-3-({1-[3-(pyridin-2-ylamino...)
Affinity DataIC50: 120nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083805(2-(Biphenyl-4-sulfonylamino)-3-({1-[3-(1H-imidazol...)
Affinity DataIC50: 130nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083834(2-(4-Acetylamino-benzenesulfonylamino)-3-({1-[3-(1...)
Affinity DataIC50: 150nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083804(3-[1-[3-(N-Pyridin-2ylamino)propyl]indazol-5-ylcar...)
Affinity DataIC50: 170nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083813(3-({1-[3-(Pyridin-2-ylamino)-propyl]-1H-indazole-5...)
Affinity DataIC50: 220nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083815(2-Isobutoxycarbonylamino-3-({1-[3-(pyridin-2-ylami...)
Affinity DataIC50: 240nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083795(2-Benzyloxycarbonylamino-3-({1-[4-(4,5-dihydro-1H-...)
Affinity DataIC50: 250nMAssay Description:Inhibition of Vitronectin receptor (alpha V beta 3) bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083837(2-(4-Chloro-benzenesulfonylamino)-3-({1-[3-(1H-imi...)
Affinity DataIC50: 260nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083798(2-Benzenesulfonylamino-3-({1-[3-(pyridin-2-ylamino...)
Affinity DataIC50: 290nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50408870(CHEMBL2111217)
Affinity DataIC50: 290nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083817(2-Benzyloxycarbonylamino-3-({1-[3-(pyridin-2-ylami...)
Affinity DataIC50: 300nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083829(3-[1-[3-(N-Pyridin-2ylamino)propyl]indazol-5-ylcar...)
Affinity DataIC50: 360nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083800(2-(Butane-1-sulfonylamino)-3-({1-[3-(pyridin-2-yla...)
Affinity DataIC50: 360nMAssay Description:Inhibitory activity against beta-3-transfected 293 cells using alpha-V beta-3 antagonism assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083834(2-(4-Acetylamino-benzenesulfonylamino)-3-({1-[3-(1...)
Affinity DataIC50: 400nMAssay Description:Inhibition of aggregation of human gel-purified platelets (GPIIbIIIa GPP)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 88 total ) | Next | Last >>
Jump to: